Log in
Enquire now
AgaMatrix

AgaMatrix

AgaMatrix is a blood Glucose Monitor founded in 2001 by Sonny Vu, Sridhar Iyengar and John Alberico.

OverviewStructured DataIssuesContributors

Contents

agamatrix.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Engineering
Engineering
Biosensor
Biosensor
Medical device
Medical device
Biomedical engineering
Biomedical engineering
Consumer electronics
Consumer electronics
0
Healthcare
Healthcare
Health technology
Health technology
Location
‌
Salem, New Hampshire
B2X
B2C
B2C
0
B2B
B2B
CEO
‌
John Alberico
Founder
Sonny Vu
Sonny Vu
Sridhar Iyengar
Sridhar Iyengar
‌
John Alberico
0
Date Incorporated
October 28, 2004
Number of Employees (Ranges)
501 – 1,000
Full Address
7 Raymond Ave, Salem, NH 03079, US
Investors
Perceptive Advisors
Perceptive Advisors
incTANK Ventures
incTANK Ventures
Collaborative Fund
Collaborative Fund
Founded Date
2001
Total Funding Amount (USD)
125,100,000
Latest Funding Round Date
July 2019
Latest Funding Type
Series C
Series C
Patents Assigned (Count)
74
Country
United States
United States

Other attributes

Company Operating Status
Active

AgaMatrix designs, develops, and manufactures products for diabetes care.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like AgaMatrix

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.